Breaking News Instant updates and real-time market news.

NVDA

Nvidia

$133.07

5.35 (4.19%)

, TMO

Thermo Fisher

$171.93

0.19 (0.11%)

10:23
05/19/17
05/19
10:23
05/19/17
10:23

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Bernstein initiated Nvidia (NVDA) with an Outperform and a $165 price target. 2. Cantor Fitzgerald initiated Thermo Fisher (TMO) with an Overweight rating and $194 price target. 3. Pacific Crest initiated IBM (IBM) with a Sector Weight rating. 4. Conduent (CNDT) initiated with a Market Perform rating and $18 price target at Cowen. 5. JMP Securities started coverage of Spring Bank Pharmaceuticals (SBPH) with a $20 price target and an Outperform rating. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

NVDA

Nvidia

$133.07

5.35 (4.19%)

TMO

Thermo Fisher

$171.93

0.19 (0.11%)

IBM

IBM

$151.90

1.12 (0.74%)

CNDT

Conduent

$16.90

0.2 (1.20%)

SBPH

Spring Bank Pharmaceuticals

$11.81

-0.19 (-1.58%)

  • 23

    May

  • 06

    Jun

  • 09

    Jun

NVDA Nvidia
$133.07

5.35 (4.19%)

05/19/17
BERN
05/19/17
INITIATION
BERN
Outperform
Nvidia initiated at Bernstein
As noted earlier, Bernstein started coverage of Nvidia with a $165 price target and an Outperform rating. The analyst thinks that the stock can rise further, driven by a large datacenter total available market, significant automotive growth, and sustainable gaming growth.
05/18/17
BERN
05/18/17
INITIATION
Target $165
BERN
Outperform
Nvidia initiated with an Outperform at Bernstein
Bernstein initiated Nvidia with an Outperform and a $165 price target.
05/15/17
GSCO
05/15/17
NO CHANGE
Target $165
GSCO
Conviction Buy
Nvidia price target raised to $165 from $130 at Goldman Sachs
Goldman Sachs analyst Toshiya Hari said hte market continues to under-appreciate Nvidia's Datacenter long-term growth opportunity. Hari was surprised by last week's launch of Volta and the associated improvement in performance and sees meaningful upside to Street estimates for FY18/19. The analyst remains positive on Nvidia's positioning in AI/ML inference market and 2020 TAM forecasts provided by the company and reiterates his Coviction Buy rating.
05/12/17
RBCM
05/12/17
NO CHANGE
RBCM
Nvidia price target raised to $150 from $138 at RBC Capital
After attending Nvidia's Analyst Day, RBC Capital analyst Mitch Steves raised his price target on Nvidia. The analyst thinks that the company's high margin data center revenue should grow by triple digit percentage levels and he estimates that its artificial intelligence revenue is increasing "more than 200%." He keeps an Outperform rating on the stock.
TMO Thermo Fisher
$171.93

0.19 (0.11%)

05/18/17
CANT
05/18/17
INITIATION
Target $194
CANT
Overweight
Thermo Fisher initiated with an Overweight at Cantor
Cantor Fitzgerald analyst Bryan Brokmeier initiated Thermo Fisher with an Overweight rating, as he sees significant opportunity for organic growth and for M&A. He set a $194 price target on Thermo Fisher, which he calls a "key beneficiary" of continued strength in biopharma.
05/16/17
JEFF
05/16/17
DOWNGRADE
Target $35
JEFF
Hold
Patheon downgraded to Hold from Buy at Jefferies
Jefferies analyst David Windley downgraded Patheon (PTHN) to Hold saying he sees little risk to the Thermo Fisher (TMO) takeover deal ultimately closing by year-end 2017. The believes the offer fairly values Patheon. The analyst raised his price target for the shares to $35 from $32.
05/15/17
PIPR
05/15/17
DOWNGRADE
Target $35
PIPR
Neutral
Patheon downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Sean Wieland downgraded Patheon (PTHN) to Neutral from Overweight and raised his price target to $35 from $33 to reflect the company's agreement to be acquired by Thermo Fisher (TMO). In his downgrade note, Wieland added that Catalent (CTLT) is comparable to Patheon and would trade at $36 if the same valuation as used in Thermo Fisher's deal is applied.
05/09/17
BOFA
05/09/17
NO CHANGE
Target $200
BOFA
Buy
Thermo Fisher added to US 1 List at BofA/Merrill
BofA/Merrill analyst Derik de Bruin added Thermo Fisher to the US 1 List following the better-than-expected Q1 report and increased its price target to $200 from $190. The analyst said Thermo is one of the best positioned life science tools companies with strong execution, improving comps ahead, and a potential end market rebound.
IBM IBM
$151.90

1.12 (0.74%)

05/16/17
MSCO
05/16/17
NO CHANGE
Target $212
MSCO
Overweight
IBM at attractive entry point ahead of mainframe cycle, says Morgan Stanley
Morgan Stanley analyst Katy Huberty attributes recent weakness in shares of IBM (IBM) to the combination of the news that Warren Buffett's Berkshire Hathaway (BRK.A) cut its stake by a third and the company's weak Q1 gross margin trends. However, growth accelerates and margins expand historically for IBM around a mainframe cycle, making the pullback an attractive entry point, according to Huberty. The analyst, who sees a number of the gross margin pressures that have recently plagued IBM abating in the second half of 2017, has a $212 price target on Big Blue's shares.
05/08/17
BERN
05/08/17
NO CHANGE
BERN
IBM shouldnt be bought on weakness, says Bernstein
Bernstein analyst A.M. (Toni) Sacconaghi, Jr.does not recommend buying IBM on weakness. The analyst says that the success of the company's turnaround efforts is "uncertain," while the stock is still expensive. The analyst keeps a Market Perform rating.
04/20/17
ARGS
04/20/17
NO CHANGE
ARGS
IBM a value play that's 'becoming a growth story,' says Argus
After IBM reported lower than expected revenue and what Argus analyst Jim Kelleher sees as "weak" gross margins, the analyst says that the stock remains a value play, given its decline from its peak prices above $215. However, the analyst thinks that the company is on the path to becoming a unique cloud and cognitive paltform" and is transitioning to "a growth story." The analyst is upbeat on the company's Watson solution and keeps a $192 price target and a Buy rating on the stock.
05/18/17
PACS
05/18/17
INITIATION
PACS
Sector Weight
IBM initiated with a Sector Weight at Pacific Crest
CNDT Conduent
$16.90

0.2 (1.20%)

02/23/17
SBSH
02/23/17
NO CHANGE
Target $17
SBSH
Buy
Citi says buy Conduent despite 'real mess' of a quarter
Citi analyst Jim Suva says Conduent is not "structurally flawed" following its "real mess" of a quarter. Much of the company's issues will be cleaned up over the next year as unprofitable contracts come off the books and charges end, Suva tells investors. He recommends buying the shares with a Buy rating and $17 price target.
01/10/17
GSCO
01/10/17
UPGRADE
Target $8.5
GSCO
Buy
Xerox upgraded to Buy from Neutral at Goldman
Goldman Sachs analyst Matthew Cabral upgraded Xerox (XRX) to Buy saying the spin-off of the company's Business Process Outsourcing businesses into Conduent (CNDT) is a "major catalyst." The move should produce greater than $1.5B in savings through 2018 and allow for targeted investments in "pockets of growth," Cabral tells investors in a research note. He lowered his price target for Xerox to $8.50 from $10.50.
05/19/17
COWN
05/19/17
INITIATION
Target $18
COWN
Market Perform
Conduent initiated with a Market Perform at Cowen
Cowen analyst Bryan Bergin initiated Conduent with a Market Perform and an $18 price target saying topline visibility is a key unknown and prefers to wait for evidence on execution.
01/26/17
SBSH
01/26/17
INITIATION
Target $17
SBSH
Buy
Conduent initiated with a Buy at Citi
Citi analyst Jim Suva started Conduent (CDNT) with a Buy rating and $17 price target. The analyst expects the Xerox (XRX) spinoff to unlock value through cost reductions and an improved focus. He also raised his price target for Xerox shares to $9 from $7.90 and keeps a Buy rating on the name.
SBPH Spring Bank Pharmaceuticals
$11.81

-0.19 (-1.58%)

08/19/16
WBLR
08/19/16
INITIATION
Target $26
WBLR
Outperform
Spring Bank Pharmaceuticals initiated with an Outperform at William Blair
William Blair analyst Y. Katherine Xu started Spring Bank Pharmaceuticals with an Outperform rating and $26 price target.
03/03/17
WBLR
03/03/17
NO CHANGE
WBLR
HBV space to consolidate over next five years, says William Blair
William Blair analyst Y. Katherine Xu sees curing chronic hepatitis B virus infections as "the next frontier" after the success of hepatitis C treatments and believes the market for an HBV cure could be "similar in size to that of HCV," or $200B in cumulative global sales over a span of two decades. She expects consolidation of the HBV market over the next five years, much like what happened with the HCV market. Xu sees Spring Bank Pharmaceuticals (SBPH) and Arbutus (ABUS) as having the strongest data catalysts in 2017, followed by Assembly Biosciences (ASMB) and Arrowhead (ARWR). She has Outperform ratings on the first three stocks and a Market Perform rating on Arrowhead.
05/02/17
CHDN
05/02/17
INITIATION
Target $16.5
CHDN
Buy
Spring Bank Pharmaceuticals initiated with a Buy at Chardan
Chardan analyst Madhu Kumar initiated Spring Bank Pharmaceuticals with a Buy and a $16.50 price target.
05/19/17
JMPS
05/19/17
INITIATION
JMPS
Outperform
Spring Bank Pharmaceuticals initiated with an Outperform at JMP Securities
JMP Securities analyst Liisa Bayko started coverage of Spring Bank with a $20 price target and an Outperform rating. She says that Spring Bank's SB9 9200 drug could become "a backbone of HBV therapy," creating a multibillion dollar revenue stream for the company.

TODAY'S FREE FLY STORIES

JUNO

Juno Therapeutics

$23.30

-2.22 (-8.70%)

18:11
05/26/17
05/26
18:11
05/26/17
18:11
Hot Stocks
Juno Therapeutics director acquires 20,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

UNH

UnitedHealth

$177.50

-0.55 (-0.31%)

18:06
05/26/17
05/26
18:06
05/26/17
18:06
Hot Stocks
UnitedHealth's OptumHealth awarded $200.5M government contract »

UnitedHealth's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

VEC

Vectrus

$29.62

0.02 (0.07%)

17:56
05/26/17
05/26
17:56
05/26/17
17:56
Hot Stocks
Vectrus Systems awarded $212.03M modification to government contract »

Vectrus Systems was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMMY

Imprimis

$3.34

-0.06 (-1.76%)

17:52
05/26/17
05/26
17:52
05/26/17
17:52
Syndicate
Breaking Syndicate news story on Imprimis »

Imprimis files $75M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRCP

IRSA Propiedades Comerciales

$43.58

-0.33 (-0.75%)

17:51
05/26/17
05/26
17:51
05/26/17
17:51
Syndicate
Breaking Syndicate news story on IRSA Propiedades Comerciales »

IRSA Propiedades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSKE

Daseke

$9.79

-0.11 (-1.11%)

17:44
05/26/17
05/26
17:44
05/26/17
17:44
Syndicate
Breaking Syndicate news story on Daseke »

Daseke files $300M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECYT

Endocyte

$2.47

0.02 (0.82%)

, RNN

Rexahn

$4.04

0.09 (2.28%)

17:35
05/26/17
05/26
17:35
05/26/17
17:35
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Endocyte (ECYT),…

ECYT

Endocyte

$2.47

0.02 (0.82%)

RNN

Rexahn

$4.04

0.09 (2.28%)

TGTX

TG Therapeutics

$12.05

0.15 (1.26%)

SGMO

Sangamo

$7.25

-0.55 (-7.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 22

    Jun

ECYT

Endocyte

$2.47

0.02 (0.82%)

17:33
05/26/17
05/26
17:33
05/26/17
17:33
Hot Stocks
Endocyte to announce updated data on EC1456, EC1169 at ASCO »

Endocyte announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

PEP

PepsiCo

$117.91

0.38 (0.32%)

17:30
05/26/17
05/26
17:30
05/26/17
17:30
Periodicals
PepsiCo in talks to acquire Vita Coco owner All Market, Reuters reports »

PepsiCo is in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCOV

Brightcove

$6.25

0.25 (4.17%)

17:25
05/26/17
05/26
17:25
05/26/17
17:25
Hot Stocks
Breaking Hot Stocks news story on Brightcove »

ESW Capital reports 8.08%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

SHIP

Seanergy Marine

$0.69

0.001244 (0.18%)

17:19
05/26/17
05/26
17:19
05/26/17
17:19
Hot Stocks
Seanergy Marine receives Nasdaq notice »

Seanergy Maritime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$10.93

0.07 (0.64%)

, DB

Deutsche Bank

$18.46

-0.39 (-2.07%)

17:10
05/26/17
05/26
17:10
05/26/17
17:10
General news
S&P advances to end week at record as Fed signals no rush to normalize policy »

The S&P 500 (SPX)…

F

Ford

$10.93

0.07 (0.64%)

DB

Deutsche Bank

$18.46

-0.39 (-2.07%)

BBY

Best Buy

$58.97

-2.28 (-3.72%)

HPQ

HP Inc.

$18.47

0.1 (0.54%)

BX

Blackstone

$32.58

0.11 (0.34%)

NOK

Nokia

$6.38

-0.02 (-0.31%)

AAPL

Apple

$153.61

-0.26 (-0.17%)

GM

General Motors

$33.07

0.47 (1.44%)

HUN

Huntsman

$24.75

-0.11 (-0.44%)

BF.A

Brown-Forman, also tag with BFA, BFB

$52.49

-0.21 (-0.40%)

BF.B

Brown-Forman, also tag with BFA, BFB

$51.73

0.13 (0.25%)

STZ

Constellation Brands

$180.93

0.79 (0.44%)

LOW

Lowe's

$80.91

-0.42 (-0.52%)

TIF

Tiffany

$86.18

0.36 (0.42%)

SHLD

Sears

$7.78

-0.7 (-8.25%)

SIG

Signet Jewelers

$49.31

-0.99 (-1.97%)

COST

Costco

$177.86

3.13 (1.79%)

ANF

Abercrombie & Fitch

$13.22

-0.83 (-5.91%)

AEO

American Eagle

$11.50

0.08 (0.70%)

EXPR

Express

$7.85

0.03 (0.38%)

TTWO

Take-Two

$77.07

-1.46 (-1.86%)

AZO

AutoZone

$615.62

8.28 (1.36%)

DSW

DSW

$16.73

-0.06 (-0.36%)

INTU

Intuit

$138.56

0.2 (0.14%)

PBYI

Puma Biotechnology

$79.75

1.7 (2.18%)

CHS

Chico's

$9.37

-0.39 (-4.00%)

SPLS

Staples

$8.98

-0.08 (-0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 31

    May

  • 31

    May

  • 01

    Jun

  • 01

    Jun

  • 01

    Jun

  • 02

    Jun

  • 06

    Jun

  • 06

    Jun

  • 06

    Jun

  • 07

    Jun

  • 12

    Jun

  • 12

    Jun

  • 13

    Jun

  • 20

    Jun

  • 28

    Jun

  • 21

    Jul

BGNE

BeiGene

$37.42

-0.04 (-0.11%)

17:07
05/26/17
05/26
17:07
05/26/17
17:07
Syndicate
Breaking Syndicate news story on BeiGene »

BeiGene files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 06

    Jun

CGI

Celadon Group

17:06
05/26/17
05/26
17:06
05/26/17
17:06
Hot Stocks
Breaking Hot Stocks news story on Celadon Group »

Litespeed Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRD

Crawford & Company Inc.

, CRDA

Crawford & Co.

$7.65

0.01 (0.13%)

17:05
05/26/17
05/26
17:05
05/26/17
17:05
Hot Stocks
Crawford & Company COO Robinson to leave company »

Crawford & Company…

CRD

Crawford & Company Inc.

CRDA

Crawford & Co.

$7.65

0.01 (0.13%)

CRDB

Crawford & Company

$9.08

-0.02 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEAS

SeaWorld

$18.08

-0.13 (-0.71%)

17:03
05/26/17
05/26
17:03
05/26/17
17:03
Hot Stocks
Breaking Hot Stocks news story on SeaWorld »

Hill Path Capital raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DMRC

Digimarc

$36.10

2.45 (7.28%)

17:03
05/26/17
05/26
17:03
05/26/17
17:03
Syndicate
Breaking Syndicate news story on Digimarc »

Digimarc files $100M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 06

    Sep

IPCI

Intellipharmaceutics

$1.94

-0.01 (-0.51%)

17:01
05/26/17
05/26
17:01
05/26/17
17:01
Syndicate
Breaking Syndicate news story on Intellipharmaceutics »

Intellipharmaceutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

GWR

Genesee & Wyoming

$66.47

0.91 (1.39%)

16:57
05/26/17
05/26
16:57
05/26/17
16:57
Hot Stocks
Genesee & Wyoming CEO Hellmann named chairman of the board »

Genesee & Wyoming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZG

Paramount Gold Nevada

$1.61

0.02 (1.26%)

16:54
05/26/17
05/26
16:54
05/26/17
16:54
Syndicate
Breaking Syndicate news story on Paramount Gold Nevada »

Paramount Gold Nevada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMO

Sangamo

$7.25

-0.55 (-7.05%)

16:53
05/26/17
05/26
16:53
05/26/17
16:53
Syndicate
Breaking Syndicate news story on Sangamo »

Sangamo files $200M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

TGTX

TG Therapeutics

$12.05

0.15 (1.26%)

16:49
05/26/17
05/26
16:49
05/26/17
16:49
Syndicate
Breaking Syndicate news story on TG Therapeutics »

TG Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 22

    Jun

AVXL

Anavex

$5.88

-0.06 (-1.01%)

16:49
05/26/17
05/26
16:49
05/26/17
16:49
Syndicate
Breaking Syndicate news story on Anavex »

Anavex files to sell 5M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EIG

Employers Holdings

$39.95

-0.4 (-0.99%)

16:42
05/26/17
05/26
16:42
05/26/17
16:42
Syndicate
Breaking Syndicate news story on Employers Holdings »

Employers Holdings files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNN

Rexahn

$4.04

0.09 (2.28%)

16:41
05/26/17
05/26
16:41
05/26/17
16:41
Syndicate
Breaking Syndicate news story on Rexahn »

Rexahn files $150M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.